⚠ For in-vitro research purposes only. Strictly not for human or veterinary use.
Australian Peptide Lab kangaroo logo
Glossary

What is Endotoxin?

Also called: Lipopolysaccharide, LPS, Bacterial endotoxin, Pyrogen

Lipopolysaccharide from the outer membrane of Gram-negative bacteria; a potent trigger of innate immune cells that survives sterilisation and can confound in-vitro assays.

By the APL Research Team · Updated

Endotoxin is lipopolysaccharide (LPS), the molecule that makes up much of the outer membrane of Gram-negative bacteria. It has three parts: lipid A, a core oligosaccharide and the O-antigen. Innate immune cells detect lipid A through the TLR4–MD-2 receptor complex, which signals through NF-κB to switch on pro-inflammatory cytokine production [1]. Endotoxin is heat-stable and remains after the bacteria that shed it are dead, so a solution can be sterile and still carry it.

Why it matters in peptide assays

Endotoxin produces a strong biological signal at concentrations that no purity method would notice, which makes it a classic source of false positives in in-vitro work.

  • Commercial reagents can carry it. A screen of reagents used in microglia research found significant LPS in a number of commercial-grade proteins, phospholipids and synthetic peptide preparations, but not in pharmaceutical-grade recombinant proteins. The LPS-binding antibiotic polymyxin B suppressed the activating effect of several commercial preparations [2].
  • Whole findings have been traced to it. Endothelial activation attributed to commercial C-reactive protein disappeared after extensive dialysis and was reproduced by azide or LPS alone at the concentrations present in the preparations [3].
  • Species changes the picture. Human and mouse TLR4–MD-2 differ in how they recognise lipid A variants [1], so the same contamination can behave differently in human and murine cells.

Assays most exposed are those reading cytokines, NF-κB reporters or activation of monocytes, macrophages, microglia or endothelial cells, including "anti-inflammatory" designs in which LPS is deliberately used as the stimulus and contamination in the test peptide quietly adds to it.

Worked example: endotoxin rides along with the dose

Suppose a peptide (molecular weight 1,500 g/mol) carries an illustrative 1 endotoxin unit (EU) per mg. The endotoxin delivered to the well scales with peptide concentration:

Peptide in wellMass concentrationEndotoxin delivered
1 µM1.5 µg/mL0.0015 EU/mL
10 µM15 µg/mL0.015 EU/mL
100 µM150 µg/mL0.15 EU/mL

Because contamination climbs a hundredfold across the range, an artefact can masquerade as a concentration–response curve that appears only at the top doses. The molarity calculator handles the µM-to-µg/mL step, and the dose–response design guide covers the controls that separate a real response from a contaminant.

How it is measured

Limulus or Tachypleus amebocyte lysate (LAL/TAL) assays, prepared from horseshoe crab blood, have long been the standard. Recombinant factor C (rFC) assays correlate closely with them, and because rFC does not respond through the factor G (glucan) pathway, they detect endotoxin more selectively [4]. Results are reported in EU. Each sample type needs a spiked control to show that the peptide itself does not suppress or enhance the reaction.

Common misunderstandings

  • "Sterile means endotoxin-free." Sterile filtration removes bacteria, not the LPS they released.
  • "99% HPLC purity covers it." Peptide purity by UV does not detect LPS at the levels that activate immune cells. Unless a certificate of analysis reports a measured endotoxin value, treat it as unknown.
  • "A heat-inactivation control will expose it." That control works for proteins, whose activity is heat-labile while LPS is not. Many short peptides survive heating too, so polymyxin B or TLR4-blocking controls discriminate better [2].

The immunomodulatory peptides guide covers peptide classes where this confound matters most.

References

  1. 1.Maeshima N, Fernandez RC. Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol. 2013. PubMed 23408095
  2. 2.Weinstein JR, Swarts S, Bishop C, et al. Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors. Glia. 2008. PubMed 17910052
  3. 3.Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2005. PubMed 15802626
  4. 4.Bolden J, Knutsen C, Levin J, et al. Currently Available Recombinant Alternatives to Horseshoe Crab Blood Lysates: Are They Comparable for the Detection of Environmental Bacterial Endotoxins? A Review. PDA J Pharm Sci Technol. 2020. PubMed 32817324

Learn more in the research library

Australian owned & operatedHPLC + mass-spec tested batchesDispatched express from Australian stockSecure Australian card payments